Results 151 to 160 of about 150,246 (305)

Neoadjuvant chemotherapy for pineal region tumors. [PDF]

J Neurooncol
Troy C, Laird DG, Brimley C, Pinto S, Himel S, Osorno-Cruz C, Motiwala M, Lesha E, Chamberlin K, Robinson G, Gajjar A, Chiang J, Shimony N, Hersh DS, Klimo P.   +14 more
europepmc   +1 more source

NEOADJUVANT CHEMOTHERAPY FOR LOCALLY ADVANCED CERVICAL CANCER

, 2016
Different modes of treatment of 78 patients with stage IIb-IIIb locally advanced cervical cancer were assessed. The study group comprised 30 patients who received 2 courses of neoadjuvant chemotherapy followed by combined curative radiation therapy.
K. A. Kolomiets, O. N. Churuksaeva
core  

Tumor Infiltrating Lymphocyte Therapy Combined With PD‐1/LAG‐3 Inhibition in Patients With Recurrent Platinum‐Resistant Ovarian Cancer

International Journal of Cancer, EarlyView.
The detection of tumor‐infiltrating lymphocytes (TILs) is a positive prognostic factor in ovarian cancer. Moreover, TILs are significantly boosted by immunotherapy, though ovarian cancer patients have seen limited benefit from immune therapies. This study investigated the safety and feasibility of TIL therapy combined with PD‐1 and LAG‐3 inhibitors in ...
Tine J. Monberg, Cathrine L. Lorentzen, Marie C. W. Westergaard, Trine Z. Iversen, Troels H. Borch, Marco Donia, Sigrid M. Mannering, Stine E. W. Banke, Özcan Met, Inge Marie Svane   +9 more
wiley   +1 more source

Neoadjuvant Chemotherapy for Male Breast Cancer: A Retrospective Cohort Study. [PDF]

Cancer Med
Yang Z, Ni P, Wang Y, Wang R, Wang B, Ren Y, Ge G, Liu F, He J, Zhou C.   +9 more
europepmc   +1 more source

Neoadjuvant chemotherapy in gynecological cancers

, 2006
Neoadjuvant chemotherapy in gynecological cancers is an approach that is shown to have positive effects on survival. It increases the rate of resectability in ovarian and cervical cancers and thus contributes to survival.
Celik, H, Yuce, K, Salman, MC, Dursun, P, Ayhan, A   +4 more
core  

Transcriptome‐Based Classification of Resected Pancreatic Ductal Adenocarcinoma Enhances Prognostic Modelling Accuracy of Overall Survival Following Adjuvant Treatment

International Journal of Cancer, EarlyView.
Outcomes after resection of pancreatic ductal adenocarcinoma remain highly variable, and existing prognostic models lack sufficient accuracy. Here, the authors aimed to improve survival prediction by integrating transcriptome‐based subtyping into a validated clinical model and applying it to a multicenter real‐world cohort of fresh‐frozen resection ...
Marjolein F. Lansbergen, Vincent R. Lanting, Paul Manoukian, Marc G. Besselink, Geert Kazemier, Ignace H. J. T. de Hingh, Mike S. L. Liem, Casper H. J. van Eijck, Erwin van der Harst, Vincent E. de Meijer, Ronald M. van Dam, Martijn W. J. Stommel, Jan Koster, Michael W. T. Tanck, Arantza Fariña Sarasqueta, Joanne Verheij, Frederike Dijk, Johanna W. Wilmink, Maarten F. Bijlsma, Hanneke W. M. van Laarhoven, for the Dutch Pancreatic Cancer Group   +20 more
wiley   +1 more source

Prognostic and Predictive Value of CD163+ Macrophages for Neoadjuvant Chemotherapy in Osteosarcoma. [PDF]

Biomedicines
Luo Y, Wang B, Feng W, Xu Z, Wu H, Yan Z, Guo H, Liu W.   +7 more
europepmc   +1 more source

Indirect Comparison of Neoadjuvant Treatment Strategies for Muscle‐Invasive Bladder Cancer: ddMVAC and Perioperative Durvalumab‐Gemcitabine‐Cisplatin Versus Gemcitabine‐Cisplatin: A Systematic Review and Network Meta‐Analysis of Randomised Controlled Trials

International Journal of Cancer, EarlyView.
Optimizing neoadjuvant therapy for muscle‐invasive bladder cancer patients who are eligible for cisplatin remains difficult, owing particularly to high toxicity and recurrence rates. This meta‐analysis compared dose‐dense methotrexate, vinblastine, doxorubicin, and cisplatin (ddMVAC) against durvalumab plus gemcitabine‐cisplatin (D‐GC) and GC alone ...
Maurin Helen Mangold, Gloria Baumann, Victoria Luise Simone Wieland, Nicolas Carl, Luisa Vivienne Renner, Alexander Studier‐Fischer, Hanna Menold, Stefanie Zschäbitz, Frederik Wessels, Niklas Westhoff, Maurice Stephan Michel, Karl‐Friedrich Kowalewski, Caelán Max Haney‐Aubert   +12 more
wiley   +1 more source

Platelet-to-Lymphocyte Ratio Multiplied by the Cytokeratin-19 Fragment Level as a Predictor of Pathological Response to Neoadjuvant Chemotherapy in Esophageal Squamous Cell Carcinoma [PDF]

[Background] The standard treatment for resectable advanced esophageal squamous cell carcinoma in Japan is surgery followed by neoadjuvant chemotherapy, and it is important to predict the effect of neoadjuvant chemotherapy before treatment.
Tokuyasu, Naruo, 16791, 16790, Matsunaga, Tomoyuki, 4296, Sakamoto, Teruhisa, 20335532, 3086, 2271, Hasegawa, Toshimichi, Fujiwara, Yoshiyuki, 3118, Makinoya, Masahiro, Miyatani, Kozo, 100000393, 100001165, 2359, 100001960, 100000156, 3600, Shishido, Yuji, 100001446, Kihara, Kyoichi, Sawata, Shohei, Takano, Shuichi, Saito, Hiroaki, 40314330, 377, 2048, 100001755, 100001316, Morimoto, Masaki, 4746, Yamamoto, Manabu, 16785, 40808953, Hanaki, Takehiko, Uejima, Chihiro, 100000374, 3905, 2212, 100001149, 100001106, 16789, 16788, 16787, 16786, Murakami, Yuki, 100000935, Miyauchi, Wataru   +49 more
core  

Chemotherapy‐Induced Nausea and Vomiting in Early Breast Cancer Patients Receiving Adjuvant Chemotherapy With Fluorouracil, Epirubicin, Cyclophosphamide Followed by Docetaxel Versus an Anthracycline‐Free Regimen With Docetaxel, Cyclophosphamide—Results From a Randomized Clinical Trial

International Journal of Cancer, EarlyView.
Chemotherapy‐induced nausea and vomiting (CINV) remains a significant clinical problem despite modern antiemetics. In particular, antiemetic strategies for emerging cancer therapies lack detailed evaluation. This randomized trial analyzed hourly CINV data for patients with early breast cancer who received either docetaxel plus cyclophosphamide (TC) or ...
Manuel Hörner, Henning Schäffler, Lothar Häberle, Chloë Goossens, Kerstin Pfister, Elena Leinert, Kristina Veselinovic, Sara Y. Brucker, Uwe Köhler, Georg Heinrich, Andreas Schneeweiss, Matthias W. Beckmann, Peter A. Fasching, Wolfgang Janni, Brigitte Rack, Sabine Heublein, Philipp Ziegler   +16 more
wiley   +1 more source